Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2017 Filed Jan 4, 2017 21:35 UTC |
Wargotz Michael HDirector
|
GrantCommon Stock | 5,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001367557-17-000002 · edgardoc.xml · nonDerivative · entry 1 Wargotz Michael H · CIK 0001367557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 F1 · date: Non Employee Director Restricted Stock Award Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:34 UTC |
KISTINGER ROBERT FDirector
|
GrantCommon Stock | 5,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001203117-17-000002 · edgardoc.xml · nonDerivative · entry 1 KISTINGER ROBERT F · CIK 0001203117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 F1 · date: Non Employee Director Restricted Stock Award Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:32 UTC |
Sarkis JoleneDirector
|
GrantCommon Stock | 5,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001236364-17-000002 · edgardoc.xml · nonDerivative · entry 1 SYKES JOLENE · CIK 0001236364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 F1 · date: Non Employee Director Restricted Stock Award Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:31 UTC |
Crawford Susan JDirector
|
GrantCommon Stock | 5,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001462890-17-000002 · edgardoc.xml · nonDerivative · entry 1 Crawford Susan J · CIK 0001462890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 F1 · date: Non Employee Director Restricted Stock Award Read SEC document |
| December 14, 2016 Filed Dec 14, 2016 21:43 UTC |
MURRAY DONALD BDirector
|
GiftCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001133824-16-000005 · edgardoc.xml · nonDerivative · entry 1 MURRAY DONALD B · CIK 0001133824 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Murray Fam Trust Disclosed balance after: 880,304 F1 · kind: Gift to Orange County Community Foundation Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 15:16 UTC |
Shih AnneDirector
|
OtherCommon Stock | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0001415988-16-000008 · edgardoc.xml · nonDerivative · entry 2 Shih Anne · CIK 0001415988 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Joint w/Spouse Disclosed balance after: 10,000 F1 · kind: Shares of stock transferred from joint account w/spouse to the following: 1,570 total shares transferred to her son (875 shares) and daughter-in-law (875 shares). Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 15:16 UTC |
Shih AnneDirector
|
OtherCommon Stock | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0001415988-16-000008 · edgardoc.xml · nonDerivative · entry 1 Shih Anne · CIK 0001415988 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Joint w/Spouse Disclosed balance after: 10,785 F1 · kind: Shares of stock transferred from joint account w/spouse to the following: 1,570 total shares transferred to her son (875 shares) and daughter-in-law (875 shares). Read SEC document |
| September 09, 2016 Filed Oct 6, 2016 22:09 UTC |
Cherbak AnthonyCEO & President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001332688-16-000014 · edgardoc.xml · derivative · entry 1 Cherbak Anthony · CIK 0001332688 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2026-09-09 F1 · derivative.exercise_date: Options vest 25% a year from date of grant. Read SEC document |
| September 09, 2016 Filed Oct 6, 2016 22:08 UTC |
DUCHENE KATE WChief Legal Officer & EVP HR
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001218774-16-000006 · edgardoc.xml · derivative · entry 1 DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2026-09-09 F1 · derivative.exercise_date: Options vest 25% a year from date of grant. Read SEC document |
| September 09, 2016 Filed Oct 11, 2016 13:48 UTC |
MUELLER HERBERT MCFO & EVP Corporate Dev.
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001249448-16-000006 · edgardoc.xml · derivative · entry 2 MUELLER HERBERT M · CIK 0001249448 · CFO & EVP Corporate Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-09-09 F1 · derivative.exercise_date: Award vests 25% after one year and 25% each year thereafter for the next three years. Read SEC document |
| September 09, 2016 Filed Oct 11, 2016 13:48 UTC |
MUELLER HERBERT MCFO & EVP Corporate Dev.
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001249448-16-000006 · edgardoc.xml · nonDerivative · entry 1 MUELLER HERBERT M · CIK 0001249448 · CFO & EVP Corporate Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,298 F1 · date: Award vests 25% after one year and 25% each year thereafter for the next three years. Read SEC document |
| September 09, 2016 Filed Oct 13, 2016 22:21 UTC |
BOWER JOHN DSr. VP of Finance
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001218772-16-000002 · edgardoc.xml · derivative · entry 1 BOWER JOHN D · CIK 0001218772 · Sr. VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-09-09 F1 · derivative.exercise_date: Options vest 25% a year from date of grant. Read SEC document |
| September 09, 2016 Filed Nov 4, 2016 20:18 UTC Amendment |
Cherbak AnthonyCEO & President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001510192-16-000148 · primary_doc.xml · derivative · entry 1 Cherbak Anthony · CIK 0001332688 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2026-09-09 F1 · derivative.exercise_price: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · derivative.exercise_price: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded. F1 · date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · date: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded. F3 · derivative.exercise_date: Options vest 25% a year from date of grant. F1 · derivative.expiration_date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Anthony Cherbak reporting the grant of 70,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Mr. Cherbak re-reporting the grant of 70,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · derivative.expiration_date: This amendment clarifies that (a) only one award of 70,000 Non-Qualified Stock Options was granted to Mr. Cherbak on September 9, 2016, with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Mr. Cherbak on September 7, 2016. Therefore the Form 4 filed for Mr. Cherbak on October 6, 2016 should be disregarded. Read SEC document |
| September 09, 2016 Filed Nov 4, 2016 20:11 UTC Amendment |
DUCHENE KATE WChief Legal Officer & EVP HR
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $14.52 | $0.00 |
DisclosureSEC source: 0001510192-16-000147 · primary_doc.xml · derivative · entry 1 DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2026-09-09 F1 · derivative.exercise_price: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · derivative.exercise_price: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded. F1 · date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · date: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded. F3 · derivative.exercise_date: Options vest 25% a year from date of grant. F1 · derivative.expiration_date: This amendment is filed to correct the Date of Earliest Transaction, Conversion or Exercise Price of Derivative Security, Transaction Date and Expiration Date as described below. On September 16, 2016, a Form 4 was filed for Kate W. Duchene reporting the grant of 38,000 Non-Qualified Stock Options on September 7, 2016. The date of the grant was actually September 9, 2016. On October 6, 2016, a second Form 4 was filed for Ms. Duchene re-reporting the grant of 38,000 Non-Qualified Stock Options to reflect the correct grant date of September 9, 2016; however, this second Form 4 did not indicate that it was an amendment to the first Form 4 filed on September 16, 2016. (Please see footnote 2 for additional information.) F2 · derivative.expiration_date: This amendment clarifies that (a) only one award of 38,000 Non-Qualified Stock Options was granted to Ms. Duchene on September 9, 2016. with a Transaction Date of September 9, 2016 and an Expiration Date of September 9, 2026, (b) the correct exercise price is $14.52, and (c) that no other or additional grants of Non-Qualified Stock Options were made to Ms. Duchene on September 7, 2016. Therefore the Form 4 filed for Ms. Duchene on October 6, 2016 should be disregarded. Read SEC document |
| September 07, 2016 Filed Sep 16, 2016 22:49 UTC |
Cherbak AnthonyCEO & President
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $15.10 | $0.00 |
DisclosureSEC source: 0001332688-16-000011 · edgardoc.xml · derivative · entry 1 Cherbak Anthony · CIK 0001332688 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2026-09-07 F1 · derivative.exercise_date: Options vest 25% a year from date of grant. Read SEC document |
| September 07, 2016 Filed Sep 16, 2016 22:48 UTC |
DUCHENE KATE WChief Legal Officer & EVP HR
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $15.10 | $0.00 |
DisclosureSEC source: 0001218774-16-000004 · edgardoc.xml · derivative · entry 1 DUCHENE KATE W · CIK 0001218774 · Chief Legal Officer & EVP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2026-09-07 F1 · derivative.exercise_date: Options vest 25% a year from date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.